An approach to patient-specific treatment of intrahepatic cholangiocarcinoma (ICC): drug screens with patient-derived spheroids identify mTOR as a viable and druggable target. (September 2018) - Toriguchi, K.; Lin, M.; Nakakura, E.; Corvera, C.; Hann, B.; Donner, D.; Warren, R.